
    
      This is a prospective, observational post-marketing surveillance study of lubiprostone in
      participants with constipation. The study will assess the safety and effectiveness of
      lubiprostone for its approved indication with real-world setting in South Korea.

      The study will enroll approximately 3000 participants. The data will be collected
      prospectively at the study sites will be recorded into electronic case report forms (e-CRFs).
      All the participants will be assigned to a single observational cohort:

      â€¢ All Participants

      The study will be conducted in South Korea. The overall duration of the study will be
      approximately 6 years. Data collection will be based on routinely scheduled visits during a
      12-month follow up period for each participant up to a final follow-up when the participant
      discontinues treatment or at the end of follow-up period for any participants still taking
      lubiprostone.
    
  